Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry | IntechOpen
We Might See A Profit From Teva Pharmaceutical Industries Limited (NYSE:TEVA) Soon
A massive lawsuit just erased $2.5 billion from drug giant Teva's market cap. Here's how much Teva and rival drugmaker Mylan could stand to lose in court. | Business Insider India